At this time, posts about Biotoxtech are rapidly increasing on portals and securities communities. Today, foreigners have net sold 33,000 shares of Biotoxtech, and institutions have net sold 45,000 shares, according to provisional data. Biotoxtech is known as a leading domestic CRO company specializing in non-clinical trials.


As of 11:30 AM on the 18th, Biotoxtech's stock price is 12,250 KRW, up 7.46% from the previous day, with a trading volume of 2,621,992 shares, which is 180.34% of the 5-day average trading volume. On September 9, Biotoxtech became a market issue with the headline "Rising along with Celltrion's positive news... rising together with Celltrion..."


In addition to Biotoxtech, posts by investors are also rapidly increasing for Synergy Innovation (048870), Abaco (083930), and Sambu Construction (001470).


Hot Picks Today

Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive) Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive)

※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing